Real-world data published in 2019-2021 showed the HPV vaccine (Gardasil/Cervarix, introduced 2006-2008) dramatically reduced cervical cancer rates in vaccinated populations, vindicating the vaccine after years of anti-vax fearmongering. Studies from Sweden, UK, and Australia showed 85-90% reductions in cervical cancer incidence among women vaccinated before age 17, with Scotland documenting zero cervical cancer cases in women born after 1995 who received the vaccine. The data represented one of the clearest vaccine success stories in modern medicine—preventing cancer with a simple shot.
The Evidence
A 2020 Swedish study tracking 1.7 million girls found an 88% cervical cancer reduction in those vaccinated before age 17, and 53% reduction even when vaccinated at 17-30. The UK reported a 97% reduction in HPV types 16 and 18 (responsible for 70% of cervical cancers) among vaccinated teens. Australia, with 80%+ vaccination rates since 2007, projected potential cervical cancer elimination by 2035. The vaccine also reduced rates of genital warts, throat cancers, and other HPV-linked diseases.
Overcoming Anti-Vax Resistance
The vaccine faced significant backlash when introduced: religious groups objected to vaccinating pre-teens against a sexually transmitted infection (fearing it would encourage promiscuity), anti-vax activists spread debunked claims about infertility and autoimmune diseases, and some parents resisted vaccinating boys (though HPV causes penile, anal, and throat cancers in men). Initial US uptake was only 30-40%. The 2019-2021 real-world data countered misinformation—you can literally prevent cancer with a vaccine, and no major side effects emerged in millions of doses.
Current Status & Access Gaps
By 2023, high-income countries with robust vaccination programs (Australia, UK, Denmark, Norway) saw cervical cancer becoming rare in vaccinated cohorts. However, global access remained unequal: low-income countries where cervical cancer kills the most people had low vaccination rates due to cost ($200-500 per full course) and distribution challenges. WHO targeted 90% vaccination rates globally by 2030 to eliminate cervical cancer as a public health threat—a rare example of a realistic “eliminate cancer” goal, entirely due to vaccination.
Sources: Lancet (Swedish study, October 2020), BMJ UK data, Cancer Council Australia projections, WHO cervical cancer elimination strategy, CDC HPV vaccination data